A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin As Adjunctive Therapy In Pediatric And Adult Subjects With Primary Generalized Tonic-clonic Seizures - Protocol A0081105
Phase of Trial: Phase III
Latest Information Update: 16 Mar 2018
At a glance
- Drugs Pregabalin (Primary)
- Indications Tonic-clonic epilepsy
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Pfizer
- 14 Jan 2018 Study has been completed in Lithuania
- 04 Jan 2018 Study has been completed in Slovakia.
- 13 Dec 2017 Planned End Date changed from 19 Mar 2019 to 30 Jun 2019.